Cleared Traditional

Electrode Market Disposable Surface Electrodes (K211839) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K211839 · Electrode Market Co., Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2021
Decision
44d
Days
Class 2
Risk

K211839 is an FDA 510(k) clearance for the Electrode Market Disposable Surface Electrodes. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Electrode Market Co., Ltd. (Ansan-Si, KR). The FDA issued a Cleared decision on July 28, 2021 after a review of 44 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Electrode Market Co., Ltd. devices

Submission Details

510(k) Number K211839 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 14, 2021
Decision Date July 28, 2021
Days to Decision 44 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
104d faster than avg
Panel avg: 148d · This submission: 44d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 97
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K211839.
Adhesive Electrode
K210448 · Shaoxing Yingtuo Healthcare Co., Ltd. · Aug 2021
Ceribell Instant EEG Headband
K210805 · Ceribell, Inc. · Aug 2021
Metallic Fabric Electrodes
K202636 · Guangzhou Xinbo Electronic Co., Ltd. · Aug 2021
BioWave BioWraps
K203158 · Biowave Corporation · Jul 2021
Well-Life Garment Electrodes (GM Series)
K200942 · Well-Life Healthcare Limited · Jun 2021
NeuroCap (Model DEC22)
K202913 · Memory MD, Inc. · Mar 2021